ARCAGY/ GINECO GROUP clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
- Minor: TEDOVA · OSE2101 Alone or in Combination With Pembrolizumab vs BSC · Platinum-sensitive Recurrent OC Trial completed
- Minor: DOMENICA · Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line Primary completion date changed from estimate of Apr 2026 to Oct 1, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 |
Disease areas by active trials
Ovarian Cancer (5) · Cervical Cancer (2) · Endometrial Cancer (2) · Sarcoma (1)
Get alerts when ARCAGY/ GINECO GROUP's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.